Clinical Trials Sponsored by Flatley Discovery Lab LLC

Total 9 results

Flatley Discovery Lab LLC

Completed

Pharmacokinetics of FDL169 in Healthy Female Subjects

Cystic Fibrosis

United Kingdom
Flatley Discovery Lab LLC

Completed

An Phase 1 Study to Evaluate the Pharmacokinetic (PK) Profile of FDL169 New Formulations in Healthy Subjects

Cystic Fibrosis

United Kingdom
Flatley Discovery Lab LLC

Completed

Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis

Cystic Fibrosis

United Kingdom
Flatley Discovery Lab LLC

Completed

FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers

Cystic Fibrosis

United Kingdom
Flatley Discovery Lab LLC

Suspended

A DDI Study of FDL169 and FDL176 in Healthy Subjects

Cystic Fibrosis

United Kingdom
Flatley Discovery Lab LLC

Completed

A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects

Cystic Fibrosis

United Kingdom
Flatley Discovery Lab LLC

Completed

A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects

Cystic Fibrosis

United Kingdom
Flatley Discovery Lab LLC

Completed

A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants

Cystic Fibrosis

Australia
Flatley Discovery Lab LLC

Completed

A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects

Cystic Fibrosis

United Kingdom, Australia, Germany, Czechia

3

Subscribe